Print

VRC 004 (03-I-0022)

A phase I clinical trial to evaluate the safety and immunogenicity of a multiclade HIV-1 DNA plasmid vaccine, VRC-HIVDNA009-00-VP, in uninfected adult volunteers

Trial Details:

I Completed
Vaccine Research Center (VRC) November 13, 2002
VRC-HIVDNA009-00-VP gagB, pol B, nef B, env A, env, B, env C
VRC-HIVDNA009-00-VP DNA
USA 50
NCT00047931
gov